Royal Bank of Canada’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.5M Sell
132,292
-36,506
-22% -$5.2M ﹤0.01% 1667
2025
Q4
$28.1M Sell
168,798
-177,663
-51% -$29.7M ﹤0.01% 1262
2025
Q3
$67.8M Buy
346,461
+115,264
+50% +$19M 0.01% 872
2025
Q2
$20.9M Buy
231,197
+78,744
+52% +$6.22M ﹤0.01% 1494
2025
Q1
$9.1M Buy
152,453
+95,409
+167% +$8.83M ﹤0.01% 1817
2024
Q4
$7.55M Buy
57,044
+11,882
+26% +$1.12M ﹤0.01% 2003
2024
Q3
$2.37M Buy
45,162
+33,030
+272% +$1.55M ﹤0.01% 2866
2024
Q2
$734K Buy
12,132
+6,108
+101% +$424K ﹤0.01% 3709
2024
Q1
$446K Buy
+6,024
New +$446K ﹤0.01% 4054

Other funds holding ALAB

Royal Bank of Canada's ALAB Position: Q1 2026 in Review

Royal Bank of Canada reduced its Astera Labs (ALAB) stake by 22% in Q1 2026, selling an estimated $5.2M and leaving 132,292 shares worth $14.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1667.

Royal Bank of Canada first reported a position in ALAB in Q1 2024 and has held it in 9 quarters since. The position peaked at $67.8M in Q3 2025. 704 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Royal Bank of Canada held 132,292 shares of Astera Labs worth $14.5M as of Q1 2026.
  • Royal Bank of Canada sold 36,506 Astera Labs shares in Q1 2026, an estimated $5.2M.
  • Astera Labs made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #1667 holding.
  • Royal Bank of Canada first reported a position in Astera Labs in Q1 2024 and has held it in 9 quarters since.
  • Royal Bank of Canada's Astera Labs position peaked at $67.8M in Q3 2025.
  • 704 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.